Turnstone Biologics

This page shows the latest Turnstone Biologics news and features for those working in and with pharma, biotech and healthcare.

Transgene slumps as viral cancer therapy fails phase 3 trial

have tied up with Turnstone Biologics and BeneVir Biopharm, respectively.

Latest news

AZ invests more in IO with Transgene oncolytic virus deal

Companies such as AbbVie and J&J both struck deals in the field last year with biotech firms – Turnstone Biologics and BeneVir Biopharm respectively. 2018 also saw Merck &Co.

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

Cancer immunotherapy: What's on the horizon?

targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’ CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

BMS’ Dr Mike Burgees joins Turnstone Biologics

He joins the immuno-oncology group as its president of R&D. Turnstone Biologics, a North American clinical-stage immuno-oncology company, has appointed Dr Mike Burgees as its president of ... He said: “ Turnstone Biologics is uniquely positioned to
Turnstone Biologics bolsters leadership team

Kris Elverum and José Otero join the group. Canadian immuno-oncology company Turnstone Biologics has strengthened its leadership team with the addition of two new hires. ... Sammy Farah, chief executive officer, Turnstone Biologics, said: “The

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...